-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURSymbol PCBK-
Sesen Bio IncBörse Börse DüsseldorfEURSymbol PCBK
-
Sesen Bio IncBörse Börse FrankfurtEURSymbol PCBK
-
Sesen Bio IncBörse Börse StuttgartEURSymbol PCBK
-
Sesen Bio IncBörse Quotrix System der Börse DüsseldorfEURSymbol PCBK
-
Sesen Bio IncBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol PCBK
-
Sesen Bio IncBörse Börse BerlinEURSymbol PCBK
-
Sesen Bio IncBörse Gettex System der Börse MünchenEURSymbol PCBK
-
Sesen Bio IncBörse NasdaqISIN US8177631053 WKN: A2JL47USDSymbol SESN
-
ISIN US8177631053 WKN: A2JL47USDSymbol SESN
-
Symbol PCBK
-
Symbol PCBK
Währung
EUR
Börse
Börse Frankfurt Zeitzone: America/New_York
Firmenname
Sesen Bio, Inc
Marktkapitalisierung
18.130.003.904 (+- 98%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
410.007.808 oder 35.850.000.000
Mitarbeiter
21 (+- 19%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
25 oder 17 Mitarbeiter
EBITDA -33.451.000
PEGRatio None
Buchwert 0.168
Dir gefallen die Informationen zu Sesen Bio Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Sesen Bio Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Sesen Bio Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Sesen Bio Inc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
62 News & Informationen zur Sesen Bio Inc Aktie
Glancy Prongay & Murray LLP, A Leading Securities Fraud Law Firm, Announces Investigation Of Sesen Bio, Inc. (SESN) On Behalf Of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sesen
INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation Of Sesen Bio, Inc. (SESN) On Behalf Of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Sesen Bio, Inc. (
15 Best Penny Stocks to Buy Now
Retail investors who do not have the billions of dollars that institutional investors have access to often look towards penny stocks as an entry into the world of investing.
Pre-market Movers: VRPX, GLG, PTIX, GLBS, AMYT, ALC…
The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT)..
66 Biggest Movers From Yesterday
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-i…
Hot Biotech Penny Stocks to Watch With Big News Right Now
Federman & Sherwood : Announces an Investigation into Sesen Bio
Federman & Sherwood announces an investigation into Sesen Bio . The complaint will allege violations of federal securities laws, Sections 10 and 20 of the Securities Exchange Act of 1934 and Rule… | August 17, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sesen Bio, Inc. – SESN
/PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sesen Bio, Inc. (“Sesen Bio” or the “Company”) (NASDAQ: SESN). Such investors…
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31% By Investing.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.31%
Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet
Toward the end of trading Monday, the Dow traded up 0.03% to 35,526.99 while the NASDAQ fell 0.34% to 14,771.91. The S&P also rose, gaining 0….
Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump
Midway through trading Monday, the Dow traded down 0.36% to 35,388.46 while the NASDAQ fell 1.24% to 14,639.36. The S&P also fell, dropping 0….
Sesen Bio Tumbles On FDA Decision To Reject BLA For Vicineum In Present Form
Sesen Bio, Inc. (SESN) shares are falling on Monday morning trade after the FDA determined that it cannot approve the BLA for Vicineum in its present form and has provided additional clinical/statistical data recommendations in addition to chemistry, manufacturing, and controls issues.
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to domin…
FDA Denies Approval Of BLA; Sesen Bio Intraday Shares Declines Over 57% : StockMarket
On Friday, shares of Sesen Bio ( SESN) , a late-stage clinical company developing antibody drugs for the treatment of cancer, plummeted over 80% in …
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04%
U.S. FDA declines to approve Sesen Bio's bladder cancer treatment, shares plunge
The U.S. drug regulator has declined to approve Sesen Bio Inc’s lead therapy candidate for a type of bladder cancer, the company said on Friday, sending its…
Sesen Bio's stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment
Shares of Sesen Bio Inc. undefined was rocked for a more than 75.4% loss on massive volume in afternoon trading Friday, after the company focused on cancer…
What's Next For Sesen Bio Stock: A Technical Analysis
Sesen Bio Inc. (NASDAQ:SESN) shares traded higher Friday on anticipation of the announcement of the company's expected FDA decision….
Sesen Bio : Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs)
Company to host conference call on Monday, August 16 at 8:00 a.m. ET
… | August 13, 2021
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 137 companies made new 52-week highs.
Areas of Significance: Johnson & Johnson (NYSE:JNJ) was the …
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is exp…
Sesen Bio Up 23%
By Josh Beckerman
Sesen Bio Inc. shares rose 23% to $4.97.
The company has said several times that it believes it is on track for a U.S. Food and Drug Administration decision on Vicineum… | August 12, 2021
Sesen Bio nears a five year high ahead of key FDA decision on cancer drug (NASDAQ:SESN)
Sesen Bio <> has added over a fifth to the market capitalization as shares reached the highest level since September 2016 on above-average volume ahead of a key milestone for…
Best Penny Stocks to Buy Now? 4 to Watch to Avoid Stock Market Crash
Sesen Bio Strengthens Executive Leadership Team As The Company Approaches The Potential Approval And Commercial Launch Of Vicineum™
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today
SESEN BIO, INC. (SESN) Reports Q2 Loss, Lags Revenue Estimates
SESEN BIO, INC. (SESN) delivered earnings and revenue surprises of -16.67% and -6.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
3 Penny Stocks to Watch That Climbed During Premarket Trading
3 Penny Stocks on Robinhood to Watch if You Like Biotech
Sesen Bio : Announces Significant Commercial Progress as the Company Approaches the Potential Approval and Launch of Vicineum™ in the US
Hiring of the US sales force is 97% complete and sales training has commenced
14 Key Opinion Leader speakers have been identified and speaker training has commenced
Two-pronged market access and… | July 26, 2021
Sesen Bio Announces Significant Commercial Progress As The Company Approaches The Potential Approval And Launch Of Vicineum™ In The US
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today
Sesen Bio : Announces New Appointments to its Board of Directors
Peter K Honig, MD, MPH and Michael A.S. Jewett, MD, FRCSC, FACS have joined the Sesen Bio Board of Directors as the Company nears potential US approval of Vicineum™ in August 2021
… | July 21, 2021
Sesen Bio Announces New Appointments To Its Board Of Directors
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today
Sesen Bio And Qilu Pharmaceutical Announce Enrollment Of First Patient In Clinical Trial For Vicineum™ In China
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and its
Sesen Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today
Are These 8 Penny Stocks to Watch on Your List Right Now?
Cramer Shares His Thoughts On Sesen Bio, Marathon Oil, More
On CNBC's
Is Sabine Royalty Trust (SBR) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending,…
Sesen Bio/Qilu Pharma's Vicineum IND application accepted for review in China (NASDAQ:SESN)
3 Penny Stocks For Your January 2021 Watch List If You Like Biotech